Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study

BACKGROUND: Simultaneous treatment of moderate-to-severe upper facial lines is reflective of real-world clinical practice. OBJECTIVE: To evaluate the efficacy and safety of daxibotulinumtoxinA-lanm for injection (DAXI) for simultaneous treatment of glabellar, forehead, and lateral canthal (LC) lines...

Descripción completa

Detalles Bibliográficos
Autores principales: Dover, Jeffrey S., Humphrey, Shannon D., Lorenc, Z. Paul, Shamban, Ava, Gross, Todd M., Rubio, Roman G., Vitarella, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760460/
https://www.ncbi.nlm.nih.gov/pubmed/36533798
http://dx.doi.org/10.1097/DSS.0000000000003637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760460/
https://www.ncbi.nlm.nih.gov/pubmed/36533798
http://dx.doi.org/10.1097/DSS.0000000000003637

Ejemplares similares